Effect of Exposure to Tobacco Smoke on Response to Anti-Tumor Necrosis Factor-Alpha Treatment in Patients with Rheumatoid Arthritis
Abstract
No Abstract.
Deighton CM (2010). Anti- TNF-alpha agents are less effective for the treatment of rheumatoid arthritis in current smok-ers. J Clin Rheumatol, 16: 15-8.
Kucukdeveci AA, Sahin H, Ataman S, Grif-fiths B, Tennant A (2004). Issues in cross-cultural validity: example from the adapta¬tion, reliability, and validity testing of a Turkish version of the Stanford Health As¬sessment Questionnaire. Arthri-tis Rheum, 51: 14-9.
Saevarsdottir S, Wedrén S, Seddighzadeh M, Bengtsson C, Wesley A, Lindblad S, Ask-ling J, Alfredsson L, Klareskog L (2011). Patients with early rheumatoid arthritis who smoke are less likely to respond to treat¬ment with methotrexate and TNF inhibi¬tors: observations from the Epide-miologi¬cal Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts. Arthritis Rheum, 63: 26-36.
Soderlin MK, Petersson IF, Geborek P (2012). The effect of smoking on re-sponse and drug survival in rheumatoid arthritis pa¬tients treated with their first an-ti-TNF drug. Scand J Rheumatol, 41: 1-9.
Söderlin MK, Andersson M, Bergman S (2013). Second-hand exposure to tobacco smoke and its effect on disease activity in Swedish rheumatoid arthritis patients. Clin Exp Rheumatol, 31: 122-4.
Mattey DL, Brownfield A, Dawes PT (2009). Relationship between packyear history of smoking and response to tumor necrosis factor antagonists in patients with rheu-ma¬toid arthritis. J Rheumatol. 36: 1180-1187.
Files | ||
Issue | Vol 45 No 3 (2016) | |
Section | Letter to the Editor |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |